Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Neoplasms of the CNS

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 65 articles: HTML format

Single Articles

May 2024
1. MEENA D, Jha S
   Autophagy in glioblastoma: A mechanistic perspective.
   Int J Cancer. 2024 May 8. doi: 10.1002/ijc.34991.
   PubMed     Abstract available
   
   
   
2. DERKS SHAE, van der Meer EL, Joosse A, de Jonge MJA, et al
   The development of brain metastases in patients with different therapeutic strategies for metastatic renal cell cancer.
   Int J Cancer. 2024 May 4. doi: 10.1002/ijc.34984.
   PubMed     Abstract available
   
   
   April 2024
3. WEIJERS DD, Hirsch S, Bakhuizen JJ, van Engelen N, et al
   Molecular analysis of cancer genomes in children with Lynch syndrome: Exploring causal associations.
   Int J Cancer. 2024;154:1455-1463.
   PubMed     Abstract available
   
   
   
4. O'NEILL K, Syed N, Crook T, Dubey S, et al
   Profiling of circulating glial cells for accurate blood-based diagnosis of glial malignancies.
   Int J Cancer. 2024;154:1298-1308.
   PubMed     Abstract available
   
   
   February 2024
5. XI S, Jiang S, Li H, Huang Q, et al
   Adult epithelioid glioblastoma exhibits an extremely poor prognosis and high frequency of SWI/SNF complex mutation: Insights from a retrospective study.
   Int J Cancer. 2024 Feb 27. doi: 10.1002/ijc.34854.
   PubMed     Abstract available
   
   
   
6. CHELLADURAI M, Xu D, Izraely S, Ben-Menachem S, et al
   A heterodimer of alpha and beta hemoglobin chains functions as an innate anticancer agent.
   Int J Cancer. 2024;154:561-572.
   PubMed     Abstract available
   
   
   January 2024
7. KEMMOTSU N, Ninomiya K, Kunimasa K, Ishino T, et al
   Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies.
   Int J Cancer. 2024;154:169-179.
   PubMed     Abstract available
   
   
   
8. HOANG TT, Schraw JM, Peckham-Gregory EC, Scheurer ME, et al
   Fetal growth and pediatric cancer: A pan-cancer analysis in 7000 cases and 37 000 controls.
   Int J Cancer. 2024;154:41-52.
   PubMed     Abstract available
   
   
   December 2023
9. MENTIS AA, Papavassiliou KA, Piperi C, Papavassiliou AG, et al
   How can cancer research be illuminated by brain research (and vice versa)?
   Int J Cancer. 2023;153:1967-1970.
   PubMed     Abstract available
   
   
   October 2023
10. LARSEN PA, Amidi A, Ghith N, Winther JF, et al
    Quality of life of adolescent and adult survivors of childhood cancer in Europe-A systematic review.
    Int J Cancer. 2023;153:1356-1375.
    PubMed     Abstract available
    
    
    September 2023
11. SIRIRUNGREUNG A, Hansen J, Ritz B, Heck JE, et al
    Association between medically diagnosed postnatal infection and childhood cancers: A matched case-control study in Denmark, 1978 to 2016.
    Int J Cancer. 2023;153:994-1002.
    PubMed     Abstract available
    
    
    July 2023
12. PROKOP G, Wiestler B, Hieber D, Withake F, et al
    Multiscale quantification of morphological heterogeneity with creation of a predictor of longer survival in glioblastoma.
    Int J Cancer. 2023 Jul 28. doi: 10.1002/ijc.34665.
    PubMed     Abstract available
    
    
    June 2023
13. GIELNIEWSKI B, Poleszak K, Roura AJ, Szadkowska P, et al
    Targeted sequencing of cancer-related genes reveals a recurrent TOP2A variant which affects DNA binding and coincides with global transcriptional changes in glioblastoma.
    Int J Cancer. 2023 Jun 20. doi: 10.1002/ijc.34631.
    PubMed     Abstract available
    
    
    
14. TSAKONAS G, Ekman S, Koulouris A, Adderley H, et al
    Safety and efficacy of immune checkpoint blockade in patients with advanced nonsmall cell lung cancer and brain metastasis.
    Int J Cancer. 2023 Jun 19. doi: 10.1002/ijc.34628.
    PubMed     Abstract available
    
    
    
15. WEISS S, Thomale UW, Schulz M, Kandels D, et al
    Neurosurgical morbidity in pediatric supratentorial midline low-grade glioma: Results from the German LGG studies.
    Int J Cancer. 2023 Jun 1. doi: 10.1002/ijc.34615.
    PubMed     Abstract available
    
    
    May 2023
16. ESLIN D, Zage PE, Bergendahl G, Lewis E, et al
    A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.
    Int J Cancer. 2023 May 29. doi: 10.1002/ijc.34569.
    PubMed     Abstract available
    
    
    
17. OFEK P, Yeini E, Arad G, Danilevsky A, et al
    Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma.
    Int J Cancer. 2023 May 4. doi: 10.1002/ijc.34545.
    PubMed     Abstract available
    
    
    April 2023
18. KANNAN S, Cheng VWT
    Nanoparticle drug delivery to target breast cancer brain metastasis: Current and future trends.
    Int J Cancer. 2023 Apr 25. doi: 10.1002/ijc.34542.
    PubMed     Abstract available
    
    
    March 2023
19. BAO H, Ren P, Liang P, Liang X, et al
    Reply to: Comments on "New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction".
    Int J Cancer. 2023 Mar 17. doi: 10.1002/ijc.34514.
    PubMed    
    
    
    
20. SABOUR S, Ghassemi F
    Comments on "New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction".
    Int J Cancer. 2023 Mar 17. doi: 10.1002/ijc.34515.
    PubMed    
    
    
    
21. YANG W, Zhao X, Zheng A, Liu Z, et al
    Identification of MET fusions in solid tumors: A multicenter, large scale study in China.
    Int J Cancer. 2023;152:1259-1268.
    PubMed     Abstract available
    
    
    January 2023
22. SCHERM A, Ippen FM, Hau P, Baurecht H, et al
    Targeted therapies in patients with newly diagnosed glioblastoma - a systematic meta-analysis of randomized clinical trials.
    Int J Cancer. 2023 Jan 16. doi: 10.1002/ijc.34433.
    PubMed     Abstract available
    
    
    December 2022
23. ZHANG S, Zhang J, Hu X, Yin S, et al
    Non-invasive Detection of Brain Gliomas Using Plasma Cell-free DNA 5-Hydroxymethylcytosine Sequencing.
    Int J Cancer. 2022 Dec 15. doi: 10.1002/ijc.34401.
    PubMed     Abstract available
    
    
    
24. GORODEZKI D, Zipfel J, Queudeville M, Holzer U, et al
    Evaluating the safety of perioperative dexamethasone treatment: A retrospective analysis of a single center pediatric low-grade glioma cohort.
    Int J Cancer. 2022 Dec 15. doi: 10.1002/ijc.34399.
    PubMed     Abstract available
    
    
    
25. MONTELLA L, Cuomo M, Del Gaudio N, Buonaiuto M, et al
    Epigenetic alterations in glioblastomas: diagnostic, prognostic and therapeutic relevance.
    Int J Cancer. 2022 Dec 7. doi: 10.1002/ijc.34381.
    PubMed     Abstract available
    
    
    November 2022
26. PETIT P, Gandon G, Chabardes S, Bonneterre V, et al
    Agricultural activities and risk of central nervous system tumors among French farm managers: Results from the TRACTOR project.
    Int J Cancer. 2022;151:1737-1749.
    PubMed     Abstract available
    
    
    
27. SELIGER C, Oppong FB, Lefranc F, Chinot O, et al
    Research Article: Association of antidepressant drug use with outcome of patients with glioblastoma.
    Int J Cancer. 2022 Nov 8. doi: 10.1002/ijc.34344.
    PubMed     Abstract available
    
    
    October 2022
28. BAO H, Ren P, Yi L, Lv Z, et al
    New Insights into Glioma Frequency Maps: From Genetic and Transcriptomic Correlate to Survival Prediction.
    Int J Cancer. 2022 Oct 28. doi: 10.1002/ijc.34336.
    PubMed     Abstract available
    
    
    
29. KHAN AB, Lee S, Serin Harmanci A, Patel R, et al
    Cxcr4 Expression is Associated with Proneural-To-Mesenchymal Transition in Glioblastoma.
    Int J Cancer. 2022 Oct 17. doi: 10.1002/ijc.34329.
    PubMed     Abstract available
    
    
    September 2022
30. MAGRI S, Musca B, Pinton L, Orecchini E, et al
    The immunosuppression pathway of tumor-associated macrophages is controlled by heme oxygenase-1 in glioblastoma patients.
    Int J Cancer. 2022 Sep 2. doi: 10.1002/ijc.34270.
    PubMed     Abstract available
    
    
    August 2022
31. TZARIDIS T, Weller J, Bachurski D, Shakeri F, et al
    "A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression".
    Int J Cancer. 2022 Aug 27. doi: 10.1002/ijc.34261.
    PubMed     Abstract available
    
    
    
32. KHALID U, Simovic M, Hammann LA, Iskar M, et al
    A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsis.
    Int J Cancer. 2022;151:590-606.
    PubMed     Abstract available
    
    
    July 2022
33. CAO J, Yan W, Li G, Zhan Z, et al
    Incidence and Survival of Benign, Borderline, and Malignant Meningioma Patients in the United States from 2004 to 2018.
    Int J Cancer. 2022 Jul 2. doi: 10.1002/ijc.34198.
    PubMed     Abstract available
    
    
    
34. SOLOMON A, Alteber Z, Bassan D, Sharbi-Yunger A, et al
    On the development of a neoantigen vaccine for the prevention of Lynch Syndrome.
    Int J Cancer. 2022;151:107-119.
    PubMed     Abstract available
    
    
    June 2022
35. ATWAL A, Snowsill T, Dandy MC, Krum T, et al
    The prevalence of mismatch repair deficiency in ovarian cancer: A systematic review and meta-analysis.
    Int J Cancer. 2022 Jun 15. doi: 10.1002/ijc.34165.
    PubMed     Abstract available
    
    
    May 2022
36. VON KNEBEL DOEBERITZ N, Paech D, Sturm D, Pusch S, et al
    Changing paradigms in oncology: toward non-cytotoxic treatments for advanced gliomas.
    Int J Cancer. 2022 May 23. doi: 10.1002/ijc.34131.
    PubMed     Abstract available
    
    
    
37. SU C, Zhou J, Qiang H, Zhao J, et al
    Special issue "The advance of solid tumor research in China": Real-world clinical outcomes of alectinib for advanced non-small-cell lung cancer patients with ALK fusion in China.
    Int J Cancer. 2022 May 17. doi: 10.1002/ijc.34123.
    PubMed     Abstract available
    
    
    February 2022
38. COGHILL AE, Kim Y, Hodge JM, Bender N, et al
    Prospective investigation of herpesvirus infection and risk of glioma.
    Int J Cancer. 2022 Feb 28. doi: 10.1002/ijc.33987.
    PubMed     Abstract available
    
    
    
39. PETROSYAN E, Fares J, Cordero A, Rashidi A, et al
    Repurposing Autophagy Regulators in Brain Tumors.
    Int J Cancer. 2022 Feb 18. doi: 10.1002/ijc.33965.
    PubMed     Abstract available
    
    
    January 2022
40. GANSER K, Eckert F, Riedel A, Stransky N, et al
    Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosis.
    Int J Cancer. 2022 Jan 27. doi: 10.1002/ijc.33950.
    PubMed     Abstract available
    
    
    December 2021
41. ZHAO Y, Li S, Yang X, Chu L, et al
    Overall survival benefit of Osimertinib and clinical value of upfront cranial local therapy in untreated EGFR-mutant non-small cell lung cancer with brain metastasis.
    Int J Cancer. 2021 Dec 16. doi: 10.1002/ijc.33904.
    PubMed     Abstract available
    
    
    September 2021
42. CHENG S, McLaughlin JR, Brown MC, Al-Sawaihey H, et al
    Childhood head trauma and the risk of childhood brain tumours: a case-control study in Ontario, Canada.
    Int J Cancer. 2021 Sep 14. doi: 10.1002/ijc.33805.
    PubMed     Abstract available
    
    
    August 2021
43. CHATTERJEE D, Chakrabarti O
    Role of stress granules in modulating senescence and promoting cancer progression: special emphasis on glioma.
    Int J Cancer. 2021 Aug 30. doi: 10.1002/ijc.33787.
    PubMed     Abstract available
    
    
    July 2021
44. LI N, Shi H, Hou P, Gao L, et al
    Genetic variants of CYP4F12 gene are associated with glioma susceptibility.
    Int J Cancer. 2021 Jul 28. doi: 10.1002/ijc.33755.
    PubMed     Abstract available
    
    
    
45. LAN C, Li H, Wang L, Zhang J, et al
    Absolute Quantification of 2-Hydroxyglutarate on Tissue by MALDI MSI for Rapid and Precise Identification of IDH Mutations in Human Glioma.
    Int J Cancer. 2021 Jul 5. doi: 10.1002/ijc.33729.
    PubMed     Abstract available
    
    
    
46. DARLIX A, Hirtz C, Mollevi C, Ginestet N, et al
    Serum GFAP is a predictor of brain metastases in patients with metastatic breast cancer.
    Int J Cancer. 2021 Jul 1. doi: 10.1002/ijc.33724.
    PubMed     Abstract available
    
    
    
47. LIU C, Huang B, Wu R, Chen J, et al
    Adequate asparaginase is important to prevent central nervous system and testicular relapse of pediatric Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.
    Int J Cancer. 2021;149:158-168.
    PubMed     Abstract available
    
    
    May 2021
48. YU X, Sheng J, Pan G, Fan Y, et al
    Real-World Utilization of EGFR TKIs and Prognostic Factors for Survival in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases.
    Int J Cancer. 2021 May 10. doi: 10.1002/ijc.33677.
    PubMed     Abstract available
    
    
    
49. HUANG W, Sundquist K, Sundquist J, Ji J, et al
    Risk of somatic diseases in offspring of survivors with childhood or adolescent central nervous system tumor in Sweden.
    Int J Cancer. 2021;148:2184-2192.
    PubMed     Abstract available
    
    
    April 2021
50. TZARIDIS T, Schafer N, Weller J, Steinbach JP, et al
    MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial.
    Int J Cancer. 2021;148:1695-1707.
    PubMed     Abstract available
    
    
    
51. SOLIMAN RM, Elhaddad A, Oke J, Eweida W, et al
    Temporal trends in childhood cancer survival in Egypt, 2007 to 2017: A large retrospective study of 14 808 children with cancer from the Children's Cancer Hospital Egypt.
    Int J Cancer. 2021;148:1562-1574.
    PubMed     Abstract available
    
    
    February 2021
52. REULEN RC, Guha J, Bright CJ, Henson KE, et al
    Risk of cerebrovascular disease among 13 457 five-year survivors of childhood cancer: A population-based cohort study.
    Int J Cancer. 2021;148:572-583.
    PubMed     Abstract available
    
    
    January 2021
53. OKAMURA R, Piccioni DE, Boichard A, Lee S, et al
    High Prevalence of Clonal Hematopoiesis-type Genomic Abnormalities in Cell-free DNA in Invasive Gliomas After Treatment.
    Int J Cancer. 2021 Jan 26. doi: 10.1002/ijc.33481.
    PubMed     Abstract available
    
    
    
54. HODGE JM, Coghill AE, Kim Y, Bender N, et al
    Toxoplasma gondii infection and the risk of adult glioma in two prospective studies.
    Int J Cancer. 2021 Jan 11. doi: 10.1002/ijc.33443.
    PubMed     Abstract available
    
    
    December 2020
55. CACCHIONE A, Lodi M, Carai A, Miele E, et al
    Upfront treatment with mTOR inhibitor everolimus in pediatric Low-Grade gliomas: A Single Center Experience.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33438.
    PubMed     Abstract available
    
    
    
56. BOGNER EM, Daly AF, Gulde S, Karhu A, et al
    miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance.
    Int J Cancer. 2020;147:3523-3538.
    PubMed     Abstract available
    
    
    
57. JUNG E, Alfonso J, Monyer H, Wick W, et al
    Neuronal signatures in cancer.
    Int J Cancer. 2020;147:3281-3291.
    PubMed     Abstract available
    
    
    November 2020
58. HUANG W, Sundquist K, Sundquist J, Ji J, et al
    Poor academic performance in offspring of survivors with childhood or adolescent central nervous system tumor in Sweden.
    Int J Cancer. 2020;147:2687-2694.
    PubMed     Abstract available
    
    
    October 2020
59. THURMAIER J, Heinemann V, Engel J, Schubert-Fritschle G, et al
    Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival.
    Int J Cancer. 2020 Oct 28. doi: 10.1002/ijc.33364.
    PubMed     Abstract available
    
    
    September 2020
60. KARALEXI MA, Dessypris N, Georgakis MK, Ryzhov A, et al
    Birth seasonality of childhood central nervous system tumors: Analysis of primary data from 16 Southern-Eastern European population-based registries.
    Int J Cancer. 2020;147:1252-1263.
    PubMed     Abstract available
    
    
    August 2020
61. HE JB, Zhang X, Guo ZW, Liu MM, et al
    Ponatinib therapy in recurrent Philadelphia chromosome-positive central nervous system leukemia with T315I mutation after Allo-HSCT.
    Int J Cancer. 2020;147:1071-1077.
    PubMed     Abstract available
    
    
    
62. GAO C, Wang F, Suki D, Strom E, et al
    Effects of systemic therapy and local therapy on outcomes of 873 breast cancer patients with metastatic breast cancer to brain: MD Anderson Cancer Center experience.
    Int J Cancer. 2020 Aug 4. doi: 10.1002/ijc.33243.
    PubMed     Abstract available
    
    
    July 2020
63. HUANG W, Sundquist K, Sundquist J, Crump C, et al
    Risk of being born preterm in offspring of survivors with childhood or adolescent central nervous system tumor in Sweden.
    Int J Cancer. 2020;147:100-106.
    PubMed     Abstract available
    
    
    June 2020
64. LAN B, Abudureheiyimu N, Zhang J, Wang C, et al
    Clinical features and prognostic factors for extracranial oligometastatic breast cancer in China.
    Int J Cancer. 2020 Jun 14. doi: 10.1002/ijc.33152.
    PubMed     Abstract available
    
    
    October 2019
65. BLAZQUEZ R, Rietkotter E, Wenske B, Wlochowitz D, et al
    LEF1 supports metastatic brain colonization by regulating glutathione metabolism and increasing ROS resistance in breast cancer.
    Int J Cancer. 2019 Oct 18. doi: 10.1002/ijc.32742.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.